Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and tolerability profile Consistent efficacy demonstrated across age groups MILAN,...
-
- Robust improvement demonstrated across diverse set of clinical measures - - Patient-reported outcomes support clinical meaningfulness of improvements in function and strength - - Meaningful...
-
Santa Barbara, CA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Bluedot Living, the rapidly expanding media company dedicated to solutions-focused climate journalism, today announced the launch of Bluedot...
-
CHARLESTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases,...
-
Plymouth Meeting, PA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- AVE, the residential real estate brand of Korman Communities, known for its national, award-winning portfolio of elevated apartments, proudly...
-
Trésorerie et équivalents de trésorerie à 122,1 millions d’euros et dépôts à court terme1 à 24,6 millions d’euros au 30 juin 2025Produit brut de 115,6 millions d’euros reçu au titre de la deuxième...
-
Cash and cash equivalents at €146.7 million including €24.6 million in short-term deposits1 as of June 30, 2025Receipt of the gross proceeds of €115.6 million from the second tranche of the structured...
-
CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Betting activity increased to 30% of consumers in Q2 2025, compared to 25% in the same period of 2024, according to a new report from TransUnion (NYSE:...
-
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release Pratteln,...
-
Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industry Based on a novel mechanism of action involving IL-32 and directly...